Translator Disclaimer
1 June 2007 DNA Vaccination of the American Crow (Corvus brachyrhynchos) Provides Partial Protection Against Lethal Challenge with West Nile Virus
Author Affiliations +
Abstract

The New York 1999 strain of West Nile virus (WNV) is nearly 100% fatal in the American crow (Corvus brachyrhynchos). We evaluated four WNV vaccine formulations in American crows, including intramuscular (i.m.) DNA vaccine, i.m. DNA vaccine with adjuvant, orally administered microencapsulated DNA vaccine, and i.m. killed vaccine. Neutralizing antibodies developed in approximately 80% of crows that received the DNA vaccine i.m. (with or without adjuvant), and in 44% that received the killed vaccine. However, no crows that received the oral microencapsulated DNA vaccine or the placebo developed WNV antibodies. All crows were challenged 10 wk after initial vaccination. No unvaccinated crows survived challenge, and survival rates were 44% (i.m. DNA vaccine), 60% (i.m. DNA vaccine with adjuvant), 0% (oral microencapsulated DNA vaccine), and 11% (killed vaccine). Peak viremia titers in the birds that survived were significantly lower as compared to titers in birds that died. Parenteral administration of a WNV DNA vaccine was associated with reduced mortality but did not provide sterile immunity.

Michel L. Bunning, Patricia E. Fox, Richard A. Bowen, Nicholas Komar, Gwong-Jen J. Chang, Tully J. Speaker, Michael R. Stephens, Nicole Nemeth, Nicholas A. Panella, Stanley A. Langevin, Paul Gordy, Max Teehee, Patricia R. Bright, and Michael J. Turell "DNA Vaccination of the American Crow (Corvus brachyrhynchos) Provides Partial Protection Against Lethal Challenge with West Nile Virus," Avian Diseases 51(2), 573-577, (1 June 2007). https://doi.org/10.1637/0005-2086(2007)51[573:DVOTAC]2.0.CO;2
Received: 22 November 2006; Accepted: 1 January 2007; Published: 1 June 2007
JOURNAL ARTICLE
5 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top